Young Investigators (e.g. Post-Graduate students, Post-doctoral fellows, Trainees, Junior faculty) are the focus of this event.
Participants should be below the age of 33 years.
Opportunity for young researchers to learn about the research areas of their peers to increase their capacity as multidisciplinary researchers
The forum will provide an opportunity for collegial interaction with other speakers and established celebrative across the globe.
Young Researcher Award will be given to the best presentation by the organizing committee member.
You may submit your presentation to any of our onsite organizers on the day of your talk. If your presentation is not compatible with our laptops, then
you may also use your own laptop.
Cell Science 2017 Organizing Committee proudly announces and invites all the participants across the globe to attend the “Annual Congress on Cell Science, Stem Cell Research & Regenerative Medicine ”slated for November 29-30 in Atlanta, USA. The theme of the conference is “Modern Research and Developments in Cell Science, Stem Cell Research” Cell Science & Stem Cell Research 2017 anticipates Cell Biologists, Stem Cell Researchers, Oncologists, Radiologists, Chemotherapists, Physicians, Academicians, Academic scientists, Industry professionals, Diagnostic laboratory professionals, Postgraduate students, Postdoctoral fellows, Trainees renowned speakers and eminent delegates across the globe to be attending the conference to share their valuable presentation and galvanize the scientific community. Scientific people from all over the globe focused on learning about emerging technologies about Cell Science & Stem Cell Research.
This is a best globalized opportunity to reach the largest assemblage of participants from the scientific community and research. Make a splash with most recent techniques, developments and the newest updates in Cell Science & Stem Cell Research and receive name recognition at this 2-days event. Cell Science, Stem Cell Research supports the biotechnology industries, research organizations, government laboratories, universities, hospitals, institutions, medical centers and biopharmaceutical industries surrounded by the life science marketplace.
Cell Science, Stem Cell Research provides insight into the full landscape of technologies, tools and business/regulatory strategies that support scientists and executives hasten the bound and efficiency of Cell Science. Cell Science & Stem Cell Research 2017 will gather a national and international delegation of renowned Cell Biologists, Stem Cell Researchers, scientists, students and professionals from Societies, organizations, academia, industry and government organizations to present and discuss current topics of cell and Stem Cells research in keynote, plenary sessions, symposia and workshops. We welcome you to submit your abstract related to the conference topics. This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists.
Cell Science 2017
CELL SCIENCE 2017 SESSIONS
Session On: Cellular Physiology and Structural Biology
The cell structure is an important target structure for drugs and bacterial pathogens. It is composed of different protein filaments that are continuously remodelled to construct a dynamic cellular scaffold. The cytoskeleton is a scaffold that gives cells their diverse and adaptable shapes and that organizes their internal structures. The cytoskeleton plays a fundamental role in all aspects of cell mechanics, such as cell adhesion and motility, cell division, intracellular transport, the establishment of cell polarity and the organization of cells in tissues and organs. Many drugs and bacterial toxins act by blocking or activating cytoskeletal regulatory proteins. We primarily investigate the regulation of the cytoskeleton in the context of cancer
Session On: Cell Biology of Vertebrates, Microbes and Parasites
Vertebrates are multicellular, heterotrophic eukaryotes with tissues that develop from embryonic layers. Biologists have identified 1.3 million living species of animals. Estimates of the total number of animal species run far higher, from 10 to 20 million to as many as 100 to 200 million.in general vertebrates are all motile, heterotropic, and multicellular. Animals are ingestive heterotrophs unlike plants, who store their food as starch,and animals store their food as glycogen. Vertebrates cells lack of cell walls that provide structural support for plants and fungi. The multicellular bodies of animals are held together by extracellular structural proteins especially collagen. Vertebrate cell s are made up of cells organized into tissues. Each tissue specialized to some specific functions .vertebrates have their unique types of intracellular junctions, including tight junctions, desmosomes. And gap junctions together. Microbes are member of the group of eukaryotic organisms that includes unicellular microorganisms such as yeasts and molds, as well as multicellular fungi that produce familiar fruiting forms known as mushrooms. These organisms are classified as a kingdom, Fungi, which is separate from the other eukaryotic life kingdoms of plants and animals.
Session On: Current Research in Cell & Molecular Biology
Stem cells have tremendous promise to help us understand and treat a range of diseases, injuries, and other health-related conditions. Their potential is evident in the use of blood stem cells to treat diseases of the blood, a therapy that has saved the lives of thousands of children with leukaemia; and can be seen in the use of stem cells for tissue grafts to treat diseases or injury to the bone, skin and surface of the eye. Some bone, skin and corneal (eye) injuries and diseases can be treated by grafting or implanting tissues, and the healing process relies on stem cells within this implanted tissue.
Session On: Nanotechnology in Stem Cells & Cancer
Nanotechnology in medicine offers some exciting possibilities. Some techniques are only imagined, while others are at various stages of testing, or actually being used today. Nanotechnologies in medicine involve applications of nanoparticles currently under development, as well as longer range research that involves the use of manufactured nano-robots to make repairs at the cellular level. Nanotechnology in medicine currently being developed involves employing nanoparticles to deliver drugs, heat, light or other substances to specific types of cells (such as cancer cells). Particles are engineered so that they are attracted to diseased cells, which allow direct treatment of those cells. This technique reduces damage to healthy cells in the body and allows for earlier detection of disease.
Session On: Germline Stem Cells
Germ cells are specialized cells which are involved in reproduction. The most well-known examples of this type of cell are gametes, the sperm and eggs which come together to create a zygote which can develop into a foetus. In addition to gametes, a number of other cells involved in reproduction are also germ cells, including gonocytes, the cells which regulate the production of eggs and sperm. All germ cells carry the germ line, the genetic material which an organism can pass on to its offspring. In humans, these cells are haploid, meaning that they carry only half the number of chromosomes necessary to create an organism. When germ cells from two different people meet, their haploid genetic material combines to create diploid cells which can replicate themselves through cell division, ultimately building a baby.
Session On: Computational Biology and Drug Designing
Computational Biology is the science of using biological data to develop algorithms and relations among various biological systems. Computational biology is different from biological computation, which is a subfield of computer science and computer engineering using bioengineering and biology to build computers, but is similar to bioinformatics, which is an interdisciplinary science using computers to store and process biological data. Computer-aided drug design methods have played a major role in the development of therapeutically important small molecules for over three decades. The field is broadly defined and includes foundations in computer science, applied mathematics, animation, statistics, biochemistry, chemistry, biophysics, molecular biology, genetics, genomics, ecology, evolution.
Session On: Cell Signaling Technology
Cell signalling is major part of communication that coordinates basic activities of cells and perform cell actions. The ability of cells to perceive and correctly respond to their microenvironment on the basis of development, tissue reform, and immunity as well as normal tissue homeostasis. Damage in cellular information processing are responsible for diseases such as cancer, autoimmunity, and diabetes. By understanding cell signalling, diseases may be treated more effectively and, theoretically, artificial tissues may be created. Cell signalling has been most studied in human diseases. Cell signalling may also occur between the cells of two different organisms. In mammals, early embryo cells exchange signals with cells of the uterus.
Session On: Cell Rejuvenation and Wound Healing
Cell Rejuvenation is described as the reforming of a damaged cell. Skin compartments, epidermis, and hair follicles house stem cells that are indispensable for skin homeostasis and regeneration. The stem cells also contribute to wound repair, resulting in restoration of tissue integrity and function of damaged tissue. Unsuccessful wound healing processes often lead to non-healing wounds. Chronic wounds are caused by depletion of stem cells and a variety of other cellular and molecular mechanisms, many of which are still poorly understood. Current chronic wound therapies are limited, so the search to develop better therapeutic strategies is on going. Adult stem cells are gaining recognition as potential candidates for numerous skin pathologies. Emerging concepts offer some perspectives on how skin tissue-engineered products can be optional.
Session On: Stem Cell Therapeutics in Modern era
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use. Research is underway to develop various sources for stem cells, and to apply stem-cell treatments for neurodegenerative diseases and conditions such as diabetes, heart disease, and other conditions. Stem-cell therapy has become controversial following developments such as the ability of scientists to isolate and culture embryonic stem cells, to create stem cells using somatic cell nuclear transfer and their use of techniques to create induced spluripotent stem cell. This controversy is often related to abortion politics and to human cloning. Additionally, efforts to market treatments based on transplant of stored umbilical cord blood have been controversial.
Session On: Cancer Cell Biology
Cancer stem cells are cancer cells that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample. CSCs are therefore tumorigenic , perhaps in contrast to other non-tumorigenic cancer cells. CSCs may generate tumours through the stem cell processes of self-renewal and differentiation into multiple cell types. Such cells are hypothesized to persist in tumours as a distinct population and cause relapse and metastasis by giving rise to new tumours. Therefore, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for patients with metastatic disease.
Session On: Tissue Engineering
Tissue engineering evolved from the field of biomaterial development and describes the practice of combining scaffolds, cells, and biologically active molecules into functional tissues. The goal of tissue engineering is to assemble functional constructs that restore, maintain, or improve damaged tissues or whole organs. Artificial skin and cartilage are examples of engineered tissues that have been approved by the FDA. This field continues to evolve. In addition to medical applications, non-therapeutic applications include using tissues as biosensors to detect biological or chemical threat agents, and tissue chips that can be used to test the toxicity of an experimental medication.
Session On: Cancer Gene Therapy
Cancer therapies are drugs or other substances that block the growth and spread of cancer by interfering with specific molecules ("molecular targets") that are involved in the growth, progression, and spread of cancer. Many cancer therapies have been approved by the Food and Drug Administration (FDA) to treat specific types of cancer. The development of targeted therapies requires the identification of good targets that is, targets that play a key role in cancer cell growth and survival. One approach to identifying potential targets is to compare the amounts of individual proteins in cancer cells with those in normal cells. Proteins that are present in cancer cells but not normal cells or that are more abundant in cancer cells would be potential targets, especially if they are known to be involved in cell growth or survival.
Session On: Bioethical Issues in Cell and Stem Cell Biology
The main Bioethical issues associated with human stem cells involve their derivation and use for research. Although there are interesting ethical issues surrounding the collection and use of somatic adult stem cells from aborted foetuses and umbilical cord blood, the most intense controversy to date has focused on the source of human embryonic stem (hES) cells. At present, new ethical issues are beginning to emerge around the derivation and use of other hES cell–like stem cells that have the capacity to differentiate into all types of human tissue. In the near future, as the stem cell field progresses closer to the clinic, additional ethical issues are likely to arise concerning the clinical translation of basic stem cell knowledge into reasonably safe, effective, and accessible patient therapies. This Review summarizes these and other bioethical issues of the past, present, and future of stem cell research.
Cell Science currently it has emerged as a rapidly diversifying field with the potential to address the worldwide organ shortage issue and comprises of tissue regeneration and organ replacement. The global tissue engineering and regeneration market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate (CAGR) of 22.3%. The global stem cell therapy market over the forecast period of 2015 to 2020. The market is poised to grow at a CAGR of 39.5% from 2012 to 2018, to reach $330 million by 2020.